Reviewing the use of corticosteroids in bronchopulmonary dysplasia

2015 Tropea, 2012, Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia, Int J Pediatr, 2012, 598606, 10.1155/2012/598606 McEvoy, 2014, Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases, Ann Am Thorac Soc, 11, s146, 10.1513/AnnalsATS.201312-424LD Bhandari, 2015, Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia, Birth Defects Res A Clin Mol Teratol, 100, 189, 10.1002/bdra.23220 Baker, 2014, Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration, Curr Opin Pediatr, 26, 306, 10.1097/MOP.0000000000000095 Laughon, 2009, Prevention of bronchopulmonary dysplasia, Semin Fetal Neonatal Med, 14, 374, 10.1016/j.siny.2009.08.002 Gien, 2011, Pathogenesis and treatment of broncopulmonary dysplasia, Curr Opin Pediatr, 23, 305, 10.1097/MOP.0b013e328346577f Jensen, 2014, Epidemiology of bronchopulmonary dysplasia, Birth Defects Res A Clin Mol Teratol, 100, 145, 10.1002/bdra.23235 Bhandari, 2006, The genetics of bronchopulmonary dysplasia, Semin Perinatol, 30, 185, 10.1053/j.semperi.2006.05.005 Trembath, 2012, Predictors of bronchopulmonary dysplasia, Clin Perinatol, 39, 585, 10.1016/j.clp.2012.06.014 National Institute of Health, 2001, Antenatal corticosteroids revisited; repeat courses. National Institute of Health Consensus Development Conference Statement, August 17‐18, 2000, Obstet Gynecol, 98, 144, 10.1097/00006250-200107000-00027 Köroğlu, 2014, Anti‐inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide‐induced amnionitis, Neonatology, 106, 235, 10.1159/000363217 Darlow, 2007, A supplementation to prevent mortality and short and long‐term morbidity in very low birthweight infants, Cochrane Database Syst Rev, CD000501 Davis, 2003, Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase, Pediatrics, 111, 469, 10.1542/peds.111.3.469 Sadeck, 2014, Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus, J Pediatr (Rio J), 90, 616, 10.1016/j.jped.2014.04.010 Lahra, 2009, Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13‐year hospital cohort study, Pediatrics, 123, 1314, 10.1542/peds.2008-0656 Doyle, 2005, Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease, Pediatrics, 115, 655, 10.1542/peds.2004-1238 Mammel, 1983, Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia, Lancet, 1, 1356, 10.1016/S0140-6736(83)92139-6 Lemons, 2001, Very low birth weight outcomes of the National Institutes of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996, Pediatrics, 107, E1, 10.1542/peds.107.1.e1 Halliday, 2010, Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev, CD001146 Committee on fetus and newborn, 2002, Postnatal corticosteroids to treat or prevent chronic lung disease in premature infants, Pediatrics, 109, 330, 10.1542/peds.109.2.330 Halliday, 2003, Moderately early (7‐14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev, CD001144 Halliday, 2003, Delayed (>3 weeks) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev, CD001145 Maggi, 2014, Preterm children have unfavorable motor, cognitive, and functional performance when compared to term children of preschool age, J Pediatr (Rio J), 90, 377, 10.1016/j.jped.2013.10.005 Doyle, 2014, An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia, J Pediatr, 165, 1258, 10.1016/j.jpeds.2014.07.049 Hentges, 2014, Association of late‐onset neonatal sepsis with late neurodevelopment in the first two years of life of preterm infants with very low birth weight, J Pediatr (Rio J), 90, 50, 10.1016/j.jped.2013.10.002 Watterberg, 2004, Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial, Pediatrics, 114, 1649, 10.1542/peds.2004-1159 Bassler, 2009, The Neonatal European Study of Inhaled Steroids (NEUROSIS): an EU‐Funded international randomised controlled trial in preterm infants, Neonatology, 97, 52, 10.1159/000227294 2015 Yeh, 2008, Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study, Pediatrics, 121, e1310, 10.1542/peds.2007-1973